Polyunsaturated fatty acids regulate cell proliferation, extracellular matrix mineralization and gene expression in a gilthead seabream skeletal cell line

Journal of Applied Ichthyology

Volumn 28, Issue 3, 2012, Pages 427-432

  Viegas, M N ^a   Dias, J ^a   Cancela, M L ^a   Laize V ^a  

^a UNIVERSITY OF ALGARVE   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ARCHOSARGUS RHOMBOIDALIS; SPARUS AURATA;

EID: 84861319375     PISSN: 01758659     EISSN: 14390426     Source Type: Journal    
DOI: 10.1111/j.1439-0426.2012.01994.x     Document Type: Article

References (41)

1. Addison, W. N.; Azari, F.; Sørensen, E. S.; Kaartinen, M. T.; McKee, M. D., 2007: Pyrophosphate inhibits mineralization of osteoblast cultures by binding to mineral, up-regulating osteopontin, and inhibiting alkaline phosphatase activity. J. Biol. Chem. 282, 15872-15883.
2. Balcerzak, M.; Hamade, E.; Zhang, L.; Pikula, S.; Azzar, G.; Radisson, J.; Bandorowicz-Pikula, J.; Buchet, R., 2003: The roles of annexins and alkaline phosphatase in mineralization process. Acta Biochim. Pol. 50, 1019-1038.
3. Bou-Gharios, G.; De Crombrugghe, B., 2008: Type I collagen structure, synthesis and regulation. In: Principles of bone biology. J. P. Bilezikian, L. G. Raisz and T. J. Martin (Eds). Elsevier, Amsterdam, The Netherlands, pp. 285-318.
4. 2 on cell proliferation and morphology of MG-63 and MC3T3-E1 osteoblast-like cells. Prostaglandins Leukot. Essent. Fatty Acids 76, 35-45.
5. Diascro, D. D. J.; Vogel, R. L.; Johnson, T. E.; Witherup, K. M.; Pitzenberger, S. M.; Rutledge, S. J.; Prescott, D. J.; Rodan, G. A.; Schmidt, A., 1998: High fatty acid content in rabbit serum is responsible for the differentiation of osteoblasts into adipocyte-like cells. J. Bone Miner. Res. 13, 96-106.
6. Ducy, P., 2000: Cbfa1: a molecular switch in osteoblast biology. Dev. Dyn. 219, 461-471.
7. Fall, P. M.; Breault, D. T.; Raisz, L. G., 1994: Inhibition of collagen synthesis by prostaglandins in the immortalized rat osteoblastic cell line Py1a: structure-activity relations and signal transduction mechanisms. J. Bone Miner. Res. 9, 1935-1943.
8. Fujimori, A.; Tsutsumi, M.; Yamada, H.; Fukase, M.; Fujita, T., 1989: Arachidonic acid stimulates cell growth in an osteoblastic cell line, MC3T3-E1, by noneicosanoid mechanism. Calcif. Tissue Int. 44, 186-191.
9. 2 production by interleukin-1α and transforming growth factor α in osteoblastic MC3T3-E1 cells. J. Bone Miner. Res. 9, 817-823.
10. Izquierdo, M. S.; Montero, D.; Robaina, L.; Caballero, M. J.; Rosenlund, G.; Ginés, R., 2005: Alterations in fillet fatty acid profile and flesh quality in gilthead seabream (Sparus aurata) fed vegetable oils for a long term period. Recovery of fatty acid profiles by fish oil feeding. Aquaculture 250, 431-444.
11. 2 on the mineralization of a clonal osteoblastic cell line (MC3T3-E1). Arch. Oral Biol. 44, 233-241.
12. Kanai, S.; Uto, K.; Honda, K.; Hagiwara, N.; Oda, H., 2011: Eicosapentaenoic acid reduces warfarin-induced arterial calcification in rats. Atherosclerosis 215, 43-51.
13. Kruger, M. C.; Schollum, L. M., 2005: Is docosahexaenoic acid more effective than eicosapentaenoic acid for increasing calcium bioavailability? Prostaglandins Leukot. Essent. Fatty Acids 73, 327-334.
14. Kruger, M. C.; Coetzee, M.; Haag, M.; Weiler, H., 2010: Long-chain polyunsaturated fatty acids: selected mechanisms of action on bone. Prog. Lipid Res. 49, 438-449.
15. Laizé, V.; Pombinho, A. R.; Cancela, M. L., 2005: Characterization of Sparus aurata osteonectin cDNA and in silico analysis of protein conserved features: evidence for more than one osteonectin in Salmonidae. Biochimie 87, 411-420.
16. Luo, G.; Ducy, P.; McKee, M. D.; Pinero, G. J.; Loyer, E.; Behringer, R. R.; Karsenty, G., 1997: Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386, 78-81.
17. 2 regulation of cyclooxygenase expression in keratinocytes is mediated via cyclic nucleotide-linked prostaglandin receptors. J. Lipid Res. 41, 873-881.
18. Massaro, M.; Habib, A.; Lubrano, L.; Turco, S. D.; Lazzerini, G.; Bourcier, T.; Weksler, B. B.; De Caterina, R., 2006: The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKCε inhibition. Proc. Natl. Acad. Sci. U. S. A. 103, 15184-15189.
19. Naylor, R. L.; Goldburg, R. J.; Primavera, J. H.; Kautsky, N.; Beveridge, M. C.; Clay, J.; Folke, C.; Lubchenco, J.; Mooney, H.; Troell, M., 2000: Effect of aquaculture on world fish supplies. Nature 405, 1017-1024.
20. Nieves, D.; Moreno, J. J., 2006: Effect of arachidonic and eicosapentaenoic acid metabolism on RAW 264.7 macrophage proliferation. J. Cell. Physiol. 208, 428-434.
21. Ogiso, B.; Hughes, F. J.; Davies, J. E.; McCulloch, C. A., 1992: Fibroblastic regulation of osteoblast function by prostaglandins. Cell. Signal. 4, 627-639.
22. Orimo, H., 2010: The mechanism of mineralization and the role of alkaline phosphatase in health and disease. J. Nihon Med. Sch. 77, 4-12.
23. Pombinho, A. R.; Laizé, V.; Molha, D. M.; Marques, S. M. P.; Cancela, M. L., 2004: Development of two bone-derived cell lines from the marine teleost Sparus aurata; evidence for extracellular matrix mineralization and cell-type-specific expression of matrix Gla protein and osteocalcin. Cell Tissue Res. 315, 393-406.
24. Poulsen, R. C.; Moughan, P. J.; Kruger, M. C., 2007: Long-chain polyunsaturated fatty acids and the regulation of bone metabolism. Exp. Biol. Med. 232, 1275-1288.
25. Rafael, M.; Laizé, V.; Cancela, M., 2006: Identification of Sparus aurata bone morphogenetic protein 2: molecular cloning, gene expression and in silico analysis of protein conserved features in vertebrates. Bone 39, 1373-1381.
26. Ringbom, T.; Huss, U.; Stenholm, Å.; Flock, S.; Skattebøl, L.; Perera, P.; Bohlin, L., 2001: COX-2 inhibitory effects of naturally occurring and modified fatty acids. J. Nat. Prod. 64, 745-749.
27. Roman, A. S.; Schreher, J.; Mackenzie, A. P.; Nathanielsz, P. W., 2006: Omega-3 fatty acids and decidual cell prostaglandin production in response to the inflammatory cytokine IL-1β. Am. J. Obstet. Gynecol. 195, 1693-1699.
28. Rouzer, C. A.; Marnett, L. J., 2003: Mechanism of free radical oxygenation of polyunsaturated fatty acids by cyclooxygenases. Chem. Rev. 103, 2239-2304.
29. Sargent, J. R.; Bell, J. G.; Bell, M. V.; Henderson, R. J.; Tocher, D. R., (1993): The metabolism of phospholipids and polyunsaturated fatty acids in fish. In: Aquaculture: fundamental and applied research. B. Lahlou and P. Vitiello (Eds). American Geophysical Union, Washington, DC, pp. 103-124.
30. Sargent, J. R.; McEvoy, L. A.; Bell, J. G., 1997: Requirements, presentation and sources of polyunsaturated fatty acids in marine fish larval feeds. Aquaculture 155, 117-127.
31. Sodek, J.; Ganss, B.; McKee, M. D., 2000: Osteopontin. Crit. Rev. Oral Biol. Med. 11, 279-303.
32. Swamy, M. V.; Cooma, I.; Patlolla, J. M. R.; Simi, B.; Reddy, B. S.; Rao, C. V., 2004: Modulation of cyclooxygenase-2 activities by the combined action of celecoxib and decosahexaenoic acid: novel strategies for colon cancer prevention and treatment. Mol. Cancer Ther. 3, 215-221.
33. Tacon, A. G. J.; Metian, M., 2008: Global overview on the use of fish meal and fish oil in industrially compounded aquafeeds: trends and future prospects. Aquaculture 285, 146-158.
34. Takuwa, Y.; Ohse, C.; Wang, E. A.; Wozney, J. M.; Yamashita, K., 1991: Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells, MC3T3-E1. Biochem. Biophys. Res. Commun. 174, 96-101.
35. Tiago, D.; Laizé, V.; Bargelloni, L.; Ferraresso, S.; Romualdi, C.; Cancela, M., 2011: Global analysis of gene expression in mineralizing fish vertebra-derived cell lines: new insights into anti-mineralogenic effect of vanadate. BMC Genomics 12, 310.
36. Turchini, G. M.; Torstensen, B. E.; Ng, W.-K., 2009: Fish oil replacement in finfish nutrition. Rev. Aquac. 1, 10-57.
37. Wang, E. A.; Rosen, V.; Cordes, P.; Hewick, R. M.; Kriz, M. J.; Luxenberg, D. P.; Sibley, B. S.; Wozney, J. M., 1988: Purification and characterization of other distinct bone-inducing factors. Proc. Natl. Acad. Sci. U. S. A. 85, 9484-9488.
38. Watkins, B. A.; Li, Y.; Allen, K. G. D.; Hoffmann, W. E.; Seifert, M. F., 2000: Dietary ratio of (n-6)/(n-3) polyunsaturated fatty acids alters the fatty acid composition of bone compartments and biomarkers of bone formation in rats. J. Nutr. 130, 2274-2284.
39. Watkins, B. A.; Li, Y.; Seifert, M. F., 2006: Dietary ratio of n-6/n-3 PUFAs and docosahexaenoic acid: actions on bone mineral and serum biomarkers in ovariectomized rats. J. Nutr. Biochem. 17, 282-289.
40. Weiler, H. A.; Fitzpatrick-Wong, S. C., 2002: Modulation of essential (n-6) (n-3) fatty acid ratios alters fatty acid status but not bone mass in piglets. J. Nutr. 132, 2667-2672.
41. Yan, Q.; Sage, E. H., 1999: SPARC, a matricellular glycoprotein with important biological functions. J. Histochem. Cytochem. 47, 1495-1505.